Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.400
+0.070 (3.00%)
At close: Apr 17, 2026, 4:00 PM EDT
2.381
-0.019 (-0.80%)
After-hours: Apr 17, 2026, 7:54 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $401.81 million as of April 17, 2026. Its market cap has increased by 13,589.42% in one year.
Market Cap
401.81M
Enterprise Value
268.50M
1-Year Change
13,589.42%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $401.81M, an increase of 435.26%. That is a compound annual growth rate of 40.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 401.81M | 14.75% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 400.77M |
| Nautilus Biotechnology | 400.58M |
| Autolus Therapeutics | 392.56M |
| Zentalis Pharmaceuticals | 392.25M |
| X4 Pharmaceuticals | 385.95M |
| Monopar Therapeutics | 382.52M |
| YD Bio | 381.49M |
| Puma Biotechnology | 380.05M |